Piper Sandler cuts target to USD 78 for Bristol Myers Squibb stock

Published on 10/27/2026 at 10:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Piper Sandler cut its target to USD 78 on October 26, 2026. Bristol Myers Squibb stock costs EUR 55.19 on October 27, 2026 before October 29 results.

Targets and earnings calendar

On October 26, 2026, Piper Sandler reduced its price target to USD 78.00 from USD 82.00.
Second-quarter revenue reached USD 12.97 billion, up 5.70 percent year over year.
Bristol Myers Squibb stock traded at EUR 55.19 at 10:38 a.m. CEST at Lang & Schwarz on October 27, 2026.
Erste Group cut its fiscal 2026 earnings-per-share estimate to USD 6.34 from USD 6.96 on October 21, 2026.

Bristol Myers Squibb, US1101221083, Illustration mit AI erstellt.

Bristol Myers Squibb (ISIN US1101221083) saw Piper Sandler cut its price target from USD 82.00 to USD 78.00 on October 26, 2026, according to MarketBeat. The company stock was trading at EUR 55.19 at Lang & Schwarz at 10:38 a.m. CEST on October 27, 2026. The next earnings report is scheduled for October 29, 2026.

Analysts are trimming estimates

The target cut came as analysts weighed Bristol Myers Squibb's pipeline against pressure on earnings expectations. MarketBeat reported that Erste Group lowered its fiscal 2026 earnings-per-share estimate to USD 6.34 from USD 6.96 on October 21, 2026, below the USD 6.51 consensus estimate and the company's USD 6.75 to USD 7.00 guidance range.

That caution contrasts with Bristol Myers Squibb's second-quarter performance. The company reported adjusted earnings per share of USD 2.04 against a USD 1.60 consensus estimate, while revenue reached USD 12.97 billion, up 5.70 percent from USD 12.27 billion a year earlier, according to MarketBeat. The figures cover the quarter ended June 30, 2026.

What do the next dates mean?

The earnings date is the key near-term test for the estimate debate. Barron's lists October 29, 2026 for third-quarter results. The company also declared a quarterly dividend of USD 0.63, with payment scheduled for November 2, 2026, according to MarketBeat.

Three recent signals shape the setup

The recent sequence began on October 5, 2026, when Leerink Partners cut its price target from USD 73.00 to USD 59.00. On October 21, 2026, Erste Group reduced its fiscal 2026 estimate from USD 6.96 to USD 6.34. On October 26, 2026, Piper Sandler lowered its target from USD 82.00 to USD 78.00. Each step kept attention on the gap between near-term earnings caution and longer-term pipeline value.

Stock trades before earnings

For investors, the immediate question is whether the October 29 report can stabilize the estimate cycle. Bristol Myers Squibb was trading at EUR 55.19 at Lang & Schwarz on October 27, 2026 at 10:38 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Bristol Myers Squibb stock.